Valuation: Haleon plc

Market Cap 29.4B 39.76B 34.26B 32.44B 55.16B 3,799B 55.44B 385B 148B 1,933B 149B 146B 6,107B P/E 2026 *
17.4x
P/E 2027 * 15.4x
Enterprise Value 36.3B 49.1B 42.3B 40.05B 68.11B 4,690B 68.45B 476B 183B 2,386B 184B 180B 7,540B EV / Sales 2026 *
3.19x
EV / Sales 2027 * 3.01x
Free-Float
98.46%
Yield 2026 *
2.42%
Yield 2027 * 2.68%

Last Transcript: Haleon plc

1 day+2.98%
1 week-0.32%
Current month-7.06%
1 month-3.77%
3 months+2.12%
6 months-11.28%
Current year-8.70%
1 week 333
Extreme 333
345.9
1 month 333
Extreme 333
374.6
Current year 317.8
Extreme 317.8
416.1
1 year 274.4
Extreme 274.4
416.1
3 years 274.4
Extreme 274.4
419.5
5 years 241.17
Extreme 241.1735
419.5
10 years 241.17
Extreme 241.1735
419.5
Manager TitleAgeSince
Chief Executive Officer 59 2021-07-21
Director of Finance/CFO 58 2024-10-31
Chief Tech/Sci/R&D Officer 63 2025-07-31
Director TitleAgeSince
Director/Board Member 59 2022-05-22
Chairman 71 2025-12-31
Director/Board Member 59 2022-07-17
Date Insider Type Main position Quantity % Market Cap. Importance
6/30/26 Free

Chief Financial Officer

283,193 0.0032%
6/30/26 Tax

Chief Financial Officer

-133,301 0.0015%
5/19/26 Others 4,415 0.0000% -
Change 5-day change 1-year change 3-year change Capi.($)
+2.52%-0.32%-4.07%+4.17% 39.76B
+3.11%+2.00%+53.22%+93.77% 994B
+1.02%-0.25%+51.32%+63.94% 640B
+2.02%+5.54%+20.66%+70.90% 454B
+5.00%+2.21%+38.79%+39.24% 337B
+1.68%-9.20%+16.65%+24.87% 261B
+3.81%+0.93%+6.48%+12.39% 246B
+0.82%-3.31%+38.54%+44.93% 204B
+1.43%-6.21%-21.04%-58.94% 190B
+1.42%-0.60%+29.52%+88.42% 178B
Average +2.28%-5.72%+23.01%+38.37% 354.45B
Weighted average by Cap. +2.35%-4.43%+34.74%+57.29%

Financials

2026 *2027 *
Net sales 11.39B 15.4B 13.27B 12.56B 21.36B 1,471B 21.47B 149B 57.37B 748B 57.83B 56.56B 2,365B 11.86B 16.04B 13.82B 13.08B 22.25B 1,532B 22.36B 155B 59.75B 779B 60.23B 58.9B 2,463B
Net income 1.69B 2.29B 1.97B 1.87B 3.18B 219B 3.19B 22.2B 8.54B 111B 8.6B 8.41B 352B 1.91B 2.59B 2.23B 2.11B 3.59B 247B 3.61B 25.08B 9.64B 126B 9.72B 9.51B 397B
Net Debt 6.9B 9.33B 8.04B 7.61B 12.95B 892B 13.01B 90.42B 34.77B 454B 35.05B 34.28B 1,433B 6.3B 8.52B 7.34B 6.95B 11.81B 814B 11.87B 82.51B 31.73B 414B 31.98B 31.28B 1,308B
Logo Haleon plc
Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (31.4%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - pain relief medicines (23.2%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - respiratory medicines (17%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; - vitamins, minerals and food supplements (15.3%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc.; - medicines for digestive health (8.9%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - other (4.2%). Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (41.6%), North America (35.1%), and Asia/Pacific (23.3%).
Employees
24,535
Date Price Change Volume
26-09-14 GBX 342.20 +2.52% 15,187,943
26-09-11 GBX 333.80 -0.71% 23,434,653
26-09-10 GBX 336.20 +0.42% 37,295,360
26-09-09 GBX 334.80 -0.74% 30,262,720
26-09-08 GBX 337.30 -1.75% 26,975,570
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
3.338GBP
Average target price
4.202GBP
Spread / Average Target
+25.89%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!